ERBB2 and breast cancer: Subsequently, to validate the phenotypic effects of the observed receptor switching in BC cells, we established clonal cell lines overexpressing HER2 or one of its DDM transgene by plasmid transfection in ZR-75-1 (another HER2-low cell line).